Testing for cardiac markers at the point of care.
Measurement of cardiac markers at the point of care is feasible, diagnostically accurate, and, when combined with appropriate decision-making algorithms, cost effective. It may be the only way to deliver results rapidly enough for therapeutic intervention.
Collinson
P O
PO
Department of Clinical Biochemistry, St. George's Hospital, London, United Kingdom. poctrop@poctrop.demon.co.uk
D000789:Angina, Unstable / Q000097:blood / Q000175:diagnosis*; D003327:Coronary Disease / Q000097:blood / Q000175:diagnosis*; D006801:Humans; D013677:Medical Laboratory Science; D009203:Myocardial Infarction / Q000097:blood / Q000175:diagnosis*; D019095:Point-of-Care Systems; D011237:Predictive Value of Tests; D011379:Prognosis; D011785:Quality Assurance, Health Care; D018570:Risk Assessment; D019210:Troponin I / Q000097:blood*; D020107:Troponin T / Q000097:blood*
D019210:Troponin I; D020107:Troponin T